INTRODUCTION
Peripheral blood lymphocytes can be divided into two major subpopulations: thymus-dependent (T)' cells and bursa-dependent (B) cells. In most species, bone marrow lymphocytes are predominantly of the B-cell type (1) (2) (3) (4) (5) . Recent studies using mice indicate that T cells and T-cell progenitors are also present in the bone marrow (6) (7) (8) (9) (10) (11) . The situation in man is unclear. Several studies have reported the absence of cells with T characteristics (4, 5, 12) while other investigators found phytohemagglutinin (PHA) and alloantigen responsive cells in human marrow (13, 14) .
In addition to lymphoid cells, bone marrow contains committed granulopoietic stem cells (CFU-C) capable of colony formation in semisolid gel. These cells and their progenitor, the pluripotent hematopoietic stem cell, are morphologically similar to lymphocytes (15, 16) . In murine systems, hematopoietic stem cells have been separated from lymphocytes by density centrifugation (7, 17) .
In order to determine if T lymphocytes are present in human marrow, we obtained multiple small aspirates from normal volunteers. Mononuclear cells were isolated by density centrifugation and studied for T-and B-lymphocyte cell surface marker and functional characteristics and for colony-forming capacity in agar.
The results indicate that substantial numbers of lymphocytes with T-cell characteristics are present in normal human bone marrow. Bone marrow T cells differ from peripheral blood T cells in their response to mitogens and alloantigens.
METHODS
Bone marrow cells. Informed consent was obtained from normal volunteers, ages 20 to 35 yr. Bone marrow was obtained from the posterior iliac crest by a sterile technique. 1-ml aliquots were carefully aspirated from separate sites along the posterior iliac crest and mixed with 500 U of preservative-free heparin. 60-ml samples of heparinized peripheral venous blood were obtained from marrow donors at the time of marrow aspiration.
Fractionation of bone marrow. The heparinized bone marrow was centrifuged (2,000 g at 24°C) for 2 min and the leukocyte-rich supernate was recovered. Antisera to A and/or B substance (Ortho Diagnostics, Raritan, N. J.) were added, as determined by the blood type of the donor, and the suspension was mixed gently for 5 min at 24°C to agglutinate the red cells. The suspension was centrifuged at 1,000 g at 24°C for 5 s and the nucleated cells recovered and carefully layered over a Ficoll-Hypaque gradient prepared according to the method of Boyum (18) . The gradient tube was then centrifuged at 1,000 g at 24°C for 2
The Journal of Clinical Investigation Volume 56 December 1975 1491-1498min. The light cell fraction (I) was collected by aspirating the interface cells. After a preliminary centrifugation at 3,000 g at 24°C for 1 min, the supernate was discarded and the cells resuspended in 'McCoy's medium (Grand Island Biological Co., Santa Clara, Calif.) and centrifuged at 1,000 g at 24°C for 7 s. The supernate contaiining the light cells was aspirated and saved, and the pellet was resuspended with McCoy's and recentrifuged. This process was repeated five times, and the supernates were pooled, washed once in TC-199 medium (Grand Island Biological Co.) and resuspended to the desired concentration.
To prepare the heavy cell fraction (I), the pellet from the Ficoll-Hypaque gradient wvas recovered and resuspended in McCoy's. Additional anti-A and/or -B antisera were added and incubated with mixing at 24'C for 3-5 min. The suspension was centrifuged at 1,000 g at 24'C for 2 s and the supernate recovered and centrifuged at 3,000 g at 24'C for 1 min. The superrate was then discarded and the pellet resuspended in Y 2Coy's and centrifuged at 1,000 g at 24°C for 15 s to remove contaminating light cells. The pelleted cells were then resuspended in TC-199 to the desired concentration. Peripheral blood lymphocytes were prepared as described above for the light cell fraction with heparinized peripheral blood. Cytocentrifuge slides of the fractionated bone marrow were stained with NMayGrunwald-Giemsa and differential counts performed.
Mixed lyinphocyte cuiltutre (MLC) . MLC studies were performed by using a one-way semimicro-technique (19 T-rosette-forminig cells (T-RFC). Spontaneous T-RFC were determined by a modification of the method previously described (20 (Fig. 3) . Approximately similar curves were observed but peripheral blood lymphocytes consistently proliferated to a greater degree than fraction I cells. Both populations tested contained an equivalent percentage of T cells (70 vs. 65%). Colony-forming capacity. Unfractionated bone marrow contained between 28 anid 140 CFtU-C per 2 X 10: marrow cells (Table VI) It is important to exclude contamination of bone marrow samples with peripheral blood as the sole source of T cells. Several arguments militate against this possibility. All marrow samples were exactly 1-ml aspirates and were carefully collected. Dicke and Lowenberg showed no increase in PHA responsiveness of marrow aliquots in a range of 0.3-3 ml (26) . While the percent of T cells (T-RFC) is comparable to peripheral blood T-lymphocyte levels, the response to mitogens and alloantigens was significantly different. Finally, the absolute number of T cells in bone marrow is too high to be accounted for by contamination with peripheral blood T cells. This data is additionally supported by the observations obtained with 5'Cr-labeled erythrocytes.
It is not clear whether bone marrow T cells are identical to peripheral blood T cells. Bone marrow T-cell progenitors in mice appear to have decreased or absent e-antigen on their surface and have different response curves to PHA and ConA (27, 28) . The situation in man may be comparable. The data on 0-antigen has not been resolved but differences in responsiveness to PHA, ConA, and alloantigens were observed in this study.
The presence of T cells in human marrow may relate to the high incidence of graft versus host disease in bone marrow transplant recipients (29) . As MLCreactive cells are hypothesized to be precursors of cells responsible for mediating graft versus host disease, fractionation of bone marrow into MLC-reactive and nonreactive populations has potentially important implications. Cells with colony-forming activity segregated with MLC-reactive cells. This is not unexpected in view of the reported lymphocytoid morphology and density of the colony-forming cell (16, 30) . There is no assay for the pluripotent stem cell in man. Nonetheless, data from animal work indicate that pluripotent stem cells, committed granulopoietic precursors (CFU-C), and bone marrow T cells and T-cell progenitors are present in light-density fractions. Even if these cells could be separated comlpletely from bone marrow, the clinical value of doing so must be questioned. For example, if T cells were selectively removed from transplanted bone marrow, functional T cells could arise in the host from precursor lymphocytes or from the pluripotent stem cell. Our data suggest that the complete spectrum of lymphoid cell differentiation is manifest in human bone 
